New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
09:15 EDTADMP, ISRG, SBUX, GWW, PTCT, XRX, KMB, MSFT, FEYE, ENDP, SWK, JNPR, KSU, IGT, BDSIOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Microsoft (MSFT), up 3.5%... Starbucks (SBUX), up 1.2%... Juniper (JNPR), up 5.4%... Kimberly Clark (KMB), up 2%... Stanley Black & Decker (SWK), up 1%. ALSO HIGHER: BioDelivery (BDSI), up 43% after announcing positive top-line results from BEMA Phase III trial with Endo (ENDP) unit... Adamis (ADMP), up 6% after receiving Notice of Allowance of patent claims for immunotherapy portfolio. DOWN AFTER EARNINGS: International Game (IGT), down 11%... Intuitive Surgical (ISRG), down 5.5%... Xerox (XRX), down 2.6%... W.W. Grainger (GWW). down 4.5%... Kansas City Southern (KSU), down 8%. ALSO LOWER: PTC Therapeutics (PTCT), down 18% after announcing EMA adopted negative opinion on MAA for Atuluren approval... FireEye (FEYE), down 2.4% following downgrade at Barclays.
News For MSFT;SBUX;JNPR;KMB;ISRG;SWK;XRX;BDSI;ENDP;PTCT;IGT;FEYE;GWW;KSU;ADMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
May 18, 2015
16:00 EDTMSFTOptions Update; May 18, 2015
Subscribe for More Information
14:42 EDTENDPAchillion rises as conference cancellation adds fuel to M&A speculation
Subscribe for More Information
13:37 EDTMSFTBaidu, Uber teaming up to pursue Nokia's maps unit, Bloomberg reports
Subscribe for More Information
10:16 EDTXRXXerox acquires Healthy Communities Institute, terms not disclosed
Subscribe for More Information
10:01 EDTKSUOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:20 EDTENDPEndo CEO says will be looking for deals on lower end of $300M-$1B range
Endo will be looking for deals similar to its Aspen transaction, the company's CEO added.
09:09 EDTENDPEndo says 'pretty large' disparity in FY16 interest expense view vs. consensus
Endo said it will not give FY16 guidance at this point but noted that there appears to be a "pretty large" disparity between the company's interest expense view for the fiscal year compared to what appears to be factored into the consensus FY16 forecast. Comments from Endo's call discussing its deal to acquire Par Pharmaceutical.
09:06 EDTFEYEFireEye announces strategic alliance with ACE Group
Subscribe for More Information
09:01 EDTFEYEMarsh, FireEye announce collaboration to offer cybersecurity readiness service
Marsh (MMC) and FireEye (FEYE) announced a collaboration to offer clients Marsh Cyber OASIS. This service is designed to assists clients by providing an objective evaluation of their organizationís ability to detect and respond to cyber-attacks, and the strength of their technical infrastructure.
09:00 EDTSBUXStarbucks management to meet with JPMorgan
Subscribe for More Information
08:27 EDTENDPEndo says Par financing structure provides flexibility for future M&A
Endo expects adjusted diluted Par EPS to grow faster than revenues, according to slides for the Par Pharmaceutical acquisition presentation. Endo anticipates returns well in excess of its cost of capital, which should enable de-levering to a projected 3-4x net debt to EBITDA in 12-18 months. Endo said the financing structure of the Par deal provides flexibility for future M&A. Endo says consolidation and maturation of competitors have stabilized the generic pharmaceuticals pricing environment and that adding Par creates a top five generics player. Endo said it will have pro forma filed ANDAs of 165 and pro forma programs in development of 152 after adding Par.
07:56 EDTKSUKansas City Southern downgraded due to lower volumes at BofA/Merrill
As previously reported, BofA/Merrill downgraded Kansas City Southern to Neutral from Buy and lowered its price target to $97 from $116. The firm said Kansas City Southern already pulled guidance and Q2 carloads to date are down 7%, versus its 1% growth forecast and coal carloads are down 44%, below its forecast of down 7%, due to large customer. Luminent, being virtually shut-down due to low natural gas prices.
07:19 EDTSWKElectric Products Group to hold a conference
EPG 2015 is being held in Longboat Key, Florida on May 18-20 with webcasted company presentations to begin on May 18 at 7:30 am; not all company presentations may be webcasted. Webcast Link
06:47 EDTKSUKansas City Southern downgraded to Neutral from Buy at BofA/Merrill
06:36 EDTENDPEndo sees PAR transaction accretive to adjusted EPS in first 12 months
Subscribe for More Information
06:34 EDTENDPEndo to acquire Par Pharmaceutical in transaction valued at $8.05B
Endo and Par Pharmaceutical announced that they have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05B, including assumption of Par debt. The combination is expected to help drive long-term double-digit revenue growth for Endo. The transaction has been unanimously approved by the boards of Endo and Par, and is supported by the management teams of both companies. There are no further shareholder approvals required. The purchase price will consist of approximately 18M shares, $1.55B of value based on the 10-day volume weighted average share price of Endo ending on May 15, of Endo equity and $6.50B cash consideration to Par shareholders. Endo has secured fully committed financing from Deutsche Bank and Barclays to fund the cash consideration. Endo expects to implement a permanent capital structure to finance the transaction prior to the close that would include a combination of cash, debt and an equity offering. The transaction is expected to close in the second half of 2015 and is subject to regulatory approval in the U.S. and certain other jurisdictions, as well as other customary closing conditions.
06:33 EDTENDPEndo to acquire Par Pharmaceutical in transaction valued at $8.05B
Subscribe for More Information
06:31 EDTENDPEndo to acquire Par Pharmaceutical in transaction valued at $8.05B
Subscribe for More Information
06:05 EDTMSFTStocks with implied volatility below IV index mean; MSFT GE
Stocks with implied volatility below IV index mean; Microsoft (MSFT) 17, General Electric (GE) 15 according to iVolatility.
May 17, 2015
14:45 EDTMSFTMicrosoft should acquire software translator Xamarin, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use